We have reported on numerous occasions of the range of proven medical treatments currently available in the fight against COVID-19.
Oddly, governments, lead by the increasingly besmirched Labor leader of Victoria, Australia, Daniel Andrews (aka: Chairman Dan, Dictator Dan) have either refused to actively pursue these treatments as effective strategies, or have ignored the mounting evidence for some form of political gain.
Lockdowns have arrived and departed from many cities around the world. Italy and Spain were the first to act, as their major population centres were hit hard by the poorly understood illness in early stages. Melbourne, Australia and Auckland, New Zealand – both led by left-wing socialist style governments have re-implemented or ratcheted-up draconian lockdown measures, effectively euthanizing their once vibrant economies.
The once highly regarded Lancet Journal was explicit in its analysis, showing that lock-downs plainly didn’t have any real and measurable positive impact on infections and or deaths.
Aside from the extensive research offering immediate treatments available right now, as reported here – and earlier, here, we are thrilled to report that there is YET ANOTHER proven treatment available.
Australia’s Australia’s Centre for Digestive Diseases issued a press release earlier this week titled “Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and Frontline Workers.”
“Triple therapy specialist Professor Thomas Borody, famous for curing peptic ulcers using a triple antibiotic therapy saving millions of lives, today released the COVID-19 treatment protocol to Australian GPs, who can legally prescribe it to their COVID-19 positive patients. They can also prescribe it as a preventative medication. Borody says this could be the fastest and safest way to end the pandemic in Australia within 6-8 weeks.”
Covexit.com has published a comprehensive piece on this exciting development. You can read the entire article here
Chart of the Day
WHO Says Covid-19 Asymptomatic Transmission Is ‘Very Rare’